Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 220 publications
Neoadjuvant Immune Checkpoint Inhibition in MSI-H/dMMR Colorectal Cancer: A Systematic Review of Prospective Trials Evaluating Efficacy, Pathologic Response, and Surgical Outcomes.
Journal: Journal of gastrointestinal cancer
Published: November 15, 2025
Pricing Trends and Overlapping Indications of Checkpoint Inhibitors for Cancer Treatment.
Journal: JCO oncology practice
Published: November 07, 2025
Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma.
Journal: Future oncology (London, England)
Published: October 30, 2025
Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer patients: demystifying the 100% clinical complete response paradigm.
Journal: The oncologist
Published: October 02, 2025
A New Direction in Endometrial Cancer Therapy-PD-1 and PD-L1 Immune Checkpoint Inhibitors-Where Will It Take Us?
Journal: Journal of clinical medicine
Published: September 29, 2025
Immunotherapy-Induced Complete Response in dMMR Rectal Cancer-A Surgical Dilemma?
Journal: Cancers
Published: September 01, 2025
Successful Immunotherapy Rechallenge Without Recurrence of Hemophagocytic Lymphohistiocytosis in a Patient With Metastatic Endometrial Cancer Previously Treated With Dostarlimab.
Journal: World journal of oncology
Published: August 25, 2025
Cytomegalovirus hepatitis after treatment with dostarlimab for colorectal cancer.
Journal: BMJ case reports
Published: August 13, 2025
Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLC.
Journal: JTO clinical and research reports
Published: August 11, 2025
Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer case.
Journal: Gynecologic oncology reports
Published: July 28, 2025
Checkpoint inhibitor rechallenge in advanced endometrial cancer: revisiting the immune landscape beyond first-line therapy.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 19, 2025
Last Updated: 01/07/2026